Digital pathology market growth: According to an exhaustive report by The Research Insights, the digital pathology market is experiencing significant growth. The worldwide digital pathology market expansion results from multiple technological advancements alongside clinical and systemic changes that mirror a comprehensive shift in diagnostic methods and healthcare service delivery. The rapid integration of AI and Machine Learning algorithms serves as a key driving force in pathology because they improve diagnostic accuracy while enhancing workflow efficiency and decision-making support. Precision medicine’ s rising requirement along with individually tailored treatment plans drives the need for digital platforms that integrate histopathological data with genomic and clinical information. The worldwide scarcity of pathologists in developing markets forces healthcare infrastructures to implement digital pathology systems that consolidate diagnostic capabilities and allow for remote consultations through telepathology. The global rise in cancer cases demands the development of diagnostic solutions that operate more quickly and can scale to meet increasing needs. The FDA’ s regulatory approvals and standardisation efforts are helping to validate digital pathology systems which leads to their broader use. The focus on digital health infrastructure and remote healthcare solutions after COVID-19 has solidified digital pathology’ s essential role in modern diagnostic processes.

Rising prevalence of chronic diseases and cancer:

The global digital pathology market is projected to be valued at US $ 1.10 billion in 2024 and reach US $ 1.73 billion by 2030, growing at a CAGR of 8 % according to a new report by The Research Insights. The key driver of this growth is the mounting need for telepathology to enable pathologists to remotely view slides and interact live over distances. The other factor is integrating Artificial Intelligence( AI) in digital pathology systems, boosting diagnostics through automated image analysis and predictive analytics.

The increasing global prevalence of chronic illnesses such as cancer alongside cardiovascular and autoimmune diseases creates demand for digital pathology through the need for accurate diagnostic results. Cancer stands as a primary focus area because the World Health Organization( WHO) reports that it causes almost 10 million deaths each year. The growing number of cancer cases increases the need for precise histopathological assessments which play a critical role in cancer staging and treatment planning as well as determining patient prognosis.

Traditional glass-slide microscopy requires extensive time commitment while demanding substantial labour effort and remains susceptible to mistakes by human operators. Digital pathology allows for complete slide digitisation which supports storage capabilities as well as analysis and sharing functions. Digital platforms play an essential role in oncology and chronic disease management through improved diagnostic accuracy and simpler access to

www. intelligenthealth. tech 63